Patent details

EP2224941 Title: USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES

Basic Information

Publication number:
EP2224941
PCT Application Number:
PCT/EP/2009/003936
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097536932
PCT Publication Number:
WO/2009/144038
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES
French Title of Invention:
UTILISATION D'INHIBITEURS DE PEPTIDES À PERMÉABILITÉ CELLULAIRE DANS LA VOIE DE TRANSDUCTION DU SIGNAL JNK POUR LE TRAITEMENT DE MALADIES DIGESTIVES INFLAMMATOIRES CHRONIQUES OU NON CHRONIQUES
German Title of Invention:
VERWENDUNG ZELLDURCHLÄSSIGER PEPTIDHEMMER DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR BEHANDLUNG CHRONISCHER ODER NICHT CHRONISCHER ENTZÜNDUNGSERKRANKUNGEN DES VERDAUUNGSTRAKTS
SPC Number:

Dates

Filing date:
02/06/2009
Grant date:
29/02/2012
EP Publication Date:
29/02/2012
PCT Publication Date:
03/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/09/2010
EP B1 Publication Date:
29/02/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/06/2019
Expiration date:
02/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/10/2013
 
 

Name:
XIGEN INFLAMMATION LTD.
Address:
ARCH. MAKARIOU III, 195 NEOCLEOUS HOUSE, 3030 LIMASSOL, Cyprus (CY)

History of Owners

From:
29/03/2012
To:
10/10/2013

Name:
Xigen S.A.
Address:
Route de la Corniche 4, 1066 Epalinges, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/04/2012
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
BONNY Christophe
Address:
Switzerland (CH)

Priority

Priority Number:
8/004340
Priority Date:
30/05/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 38/01;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
22/10/2018
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
PAVIS GMBH
Filing date Document type Number of pages